[The exogenous plasmin phase in fibrinolytic therapy].
D005341:Fibrinolysin / Q000009:adverse effects / Q000627:therapeutic use*; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000209:etiology; D006801:Humans; D007263:Infusions, Parenteral; D008722:Methods; D010949:Plasma; D010952:Plasma Substitutes / Q000627:therapeutic use; D013916:Thrombelastography; D013927:Thrombosis / Q000188:drug therapy*; D013997:Time Factors
D010952:Plasma Substitutes; D005341:Fibrinolysin
Die exogene Plasminphase in der fibrinolytischen Therapie.